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A minor criticism of the book, is that few of the practical
protocols quoted seem to have been improved by application
in the authors' own laboratory. If one uses a technique
regularly, it is usual to come up with little ways ofimproving
the method. In this book, most of the protocols seem to be
copied unchanged from the original source. For example, in
protocol 3.11 on performing DNA measurements from para-
ffin-embedded material, the authors suggest the use of 30 ym
sections, whilst it has been recognised for some time, that
this is not the optimum and that 50 m sections often give
significantly better results. Further, many laboratories have
automated this technique, to make it quicker and more con-
venient to perform.
Although I have used Chapter 3 as an example, my im-
pression is that these criticisms apply throughout the book.
Undoubtedly, this book contains useful information but the
market for flow cytometry books is becoming more com-
petitive. From the middle of 1990 to mid-1992, at least eight
flow cytometry books have, or are scheduled to, appear on
the market. Thus, any new book needs to have a clear
objective and to be well written and organised. In my view,
this book tends to fall between stools in its aims, and could
have benefited from a better level of organisation. Given the
availability of alternative books, I would find it hard to
recommend this book to new colleagues or students.
R.S. Camplejohn
Hematopoietic Growth Factors in Clinical Applications
Edited by R. Mertelsmann and R. Herrmann, New York:
Marcel Dekker Inc., 1990, 240 pp. $99.75 (USA and
Canada), $199.50 (Others).
Since the first haemopoietic growth factors became available
for clinical testing over 5 years ago, there has been a rapid
expansion in the literature. The two editors Roland Mertels-
mann and Friedhelm Herrmann of this multi-author text,
have made major contributions to this field. They have invit-
ed contributors to initially address the biology and basic
concepts of haemopoietic growth factors before embarking
on clincial applications.
As might be expected with over 75 authors, there is some
repetition and the standard of contribution varies. The pre-
clinical chapters give a good review of the cytokines available
for testing, their production, mechanism ofaction, and recep-
tor expression. The book then naturally progresses to the
studies in sub-human primates before coming through to
man. The clinical data are predominantly from Phase I and
II trials of Granulocyte and Granulocyte-Macrophage Col-
ony Stimulating Factors, although data are presented on
Erythropoietin and Interleukin-3. This section deals mainly
with reduction in the period of neutropenia after chemo-
therapy or bone marrow transplantation, but there are also
chapters on myelodysplasia and aplastic anaemia. There is an
interesting section on the effect of colony stimulating factors
on malignant cells. This concentrates predominantly on the
potentially advantageous use of these agents to recruit mye-
loid leukaemic cells into cycle prior to chemotherapy. The
book concludes with pre-clinical data on Interleukin 4 and 6
which have just entered clinical trials.
It may be slightly too early to give firm recommendation
for the clinical indication for the use of haemopoietic growth
factors, but I felt that an attempt should have been made to
have a chapter in which the clinical data presented were
critically evaluated. Now that these agents are being market-
ed, I suspect that clinicians having read the title of this book
would have expected more guidance and help on the best
way to utilise these powerful agents in the most cost bene-
ficial manner for their patients. With the plethora of talent
and experience available from the authors contributing to
this book, it should have been possible to entice one of them
to have written this finale.
A review at this time can only be a 'snapshot' of this
rapidly progressing field. Readers will, however, find that this
review will give them an excellent basis of knowledge critic-
ally to evaluate publications as they appear. It will appeal
predominantly to clinicians wishing to rapidly assimilate the
basic science as well as the clinical results.
J.H. Scarffe
Cancer Screening
edited by A.B. Miller, J. Chamberlain, N.E. Day, M.
Hakama and P.C. Prorok, Cambridge: Cambridge University
Press, 1991, 438 pp. £45.00, $85.00.
This book is the report of a workshop 'to uptake conclusions
on screening for cancer of sites previously considered, and to
evaluate some new sites' held in April 1990 and is the fifth
monograph arising from the UICC Project on Evaluation of
Screening for Cancer. In one volume the 'State of the Art' on
screening for cancers of the breast, colorectum, cervix, ovary,
prostate, stomach, nasopharynx, and for malignant mela-
noma and neuroblastoma is brought together. Each cancer is
reported in a separate section comprising a number of
chapters (44 in all) written by 88 experts.
Each section begins with a brief summary of the state of
the art on screening for that particular cancer including a list
of recommendations for research. This is followed by a
number of chapters from different authors' presentations at
the workshop and finally an edited summary of the discus-
sion. The book is clearly laid out for reference purposes and
presents the concepts of screening straightforwardly. The
Editors state, in their Preface, that the book is targeted at
those 'interested in screening for cancer including govern-
ment and non-government organisations concerned with
cancer control' and cancer researchers. Experts in cancer-
screening may find the book rather too simple but it is
pitched at the right level for the non-expert. Those hoping
that the book will summarise the results of all the various
studies to date will be disappointed; in Chapter 1 on the UK
Trial, for example, the discussion is mainly concerned with
sensitivity, specificity and biopsy rates.
The first section on breast cancer contains five chapters
each on one of the well-known trials of screening - the UK
trial, the trials from Finland, the Swedish 2-County trial, the
Malmo trial and that from Canada. Different aspects of these
studies are described and some of the puzzling differences in
results discussed. A sixth chapter on breast self-examination
(BSE) as a strategy for downstaging in developing countries
and the importance, and feasibility, of giving adequate treat-
ment without major technological investment is unfortunately
too early to give any results of the USSR/Germany/WHO
trial. A clearly presented account ofthe principles involved in
different types of cost-effectiveness analysis completes this
section.
The section on cervical screening includes chapters on
natural history, a description of the screening programmes in
the Nordic countries indicating the stark contrast between
the success of the best-organised programmes there to the
relative lack of success of the programmes in Canada, and
indeed in the UK. The importance of 'political will' in ensur-
ing the success of national programmes and the difficulties of
reducing the overscreening of low-risk groups are rightly
emphasised. Chapter 18 contains an excellent discussion of
the evidence for the effect oftiming ofreferral for colposcopy
in terms of degree of dysplasia. While the first four chapters
in the section consider cervical screening in developing coun-
tries where as few as 5% of women may have been screened
within the previous 5 years. The enormous problems of
setting up and evaluating even the simplest of organised
programmes (which have in the past at least, defeated even-
some developed countries) are discussed. This surely must be
a major challenge for preventative medicine in the next
decade.
Sections 1 and 3 thus discuss two cancer sites where there
is sufficient evidence of the potential or actual advantages of416 BOOK REVIEWS
screening to warrant screening programmes as a matter of
public health policy. The remaining sections are devoted to
those cancers where screening is a research activity and where
to date insufficient evidence has accrued to justify public
health policies on screening. Recommendations for the
research necessary to reach a decision as to whether a
national screening program is cost-effective are given. There
are indications that for most cancers there is a long way to
go while for others (for example, prostate cancer) there are
strong contraindications for large scale screening.
This book is useful reading for all those involved in actual
or potential screening programmes, and its references provide
well for those who wish to read further. I would particularly
recommend it to clinicians interested in screening as the
wider public health implications and cost-effectiveness aspects
are emphasised throughout.
C.E.D. Chilvers
Immunoscintigraphy, Practical Aspects and Clinical Applications
A.C. Perkins & M.V. Pimm, New York: John Wiley & Sons
Ltd, 1991, 193 pp. $59.95.
The authors state in their preface that the book is not an
all-encompassing textbook, but intended more as an intro-
ductory handbook for personnel of nuclear medicine depart-
ments. We must agree that they have succeeded in presenting
us with one such primer, managing to put together a concise
yet detailed text, very rarely sacrificing content for brevity
and yet keeping the amount of material in a manageable size
of 168 very readable pages. This book fills a gap in existing
literature in Nuclear Medicine. The quality of the material is
consistent throughout, and the clarity and readability of the
text reflects the authors' experience in this field.
The volume is a handsomely edited book. The material is
laid out in 8 carefully chosen chapters, the first three address-
ing preclinical aspects of the use of monoclonal antibodies,
one (ch. 5) on the technical considerations of immunoscinti-
graphy, and four chapters dealing with the clinical applica-
tion of the technique per se. A useful glossary complements
the text.
The first chapter provides a good overview of production/
purification procedures, giving the new initiate a clear overall
idea of the techniques and problems associated with the
manufacture of monoclonal antibodies. The second chapter
describes methods of labelling antibodies for scintigraphic
purposes; although improvements in chelator efficiency with
the introduction of the macrocyclic chelating agents may be
more pertinent in a discussion of radioimmunotherapy, at
least a passing comment with some references would have
made for a more complete treatment of the subject.
The third chapter is a balanced and un-biased exposition
of the role of pre-clinical evaluation of antibodies in animals
models. Some elegant work of the authors' is presented, the
corollary though being (p. 82) '. . . the true clinical value of
an antibody will not be realised until it has been tested in
patients.'
Chapter four entitled: 'Administration of Antibodies to
Patients', despite having to bring together a rather large
array of heterogeneous information, ranging from ethico/legal
considerations governing the administration of antibodies
and protocol design, to pharmacokinetic and biodistribution
characteristics of antibodies in patients, manages to negotiate
the material in a lucid and informative manner.
Chapter five describes the technical aspects, considerations
and variants introduced to routine scintigraphy to accom-
modate for pecularities of the use of immunoradiopharma-
ceuticals. It is well balanced and clearly presented. However
we feel that a table like 5.4 with the authors' recommenda-
tions for routine immunoscintigraphy would have made for a
more complete picture.
The next two chapters address the major objective of the
book, which is to give a spectrum of the current and possible
applications of immunoscintigraphy in clinical practice. The
objective is attained remarkably well and it is to the author's
credit that overoptimism does not intrude into their critical
evaluation of the current clinical applications, problems and
efficacy of immunoscintigraphy. The last chapter gives a very
good account of possible innovations that may realise the
exciting potential of this tool.
In conclusion this is a well-balanced, succinct text which
achieves the objectives it sets out to accomplish. We would
happily recommend it as useful reading for any physician
contemplating postgraduate studies in this field.
A. Maraveyas
A.A. Epenetos
Tumours of the Epidermis
K. Hashimoto & A.H. Mehregan. Boston: Butterworth
Scientific, 1991, 270pp. £45.00.
This volume is the third in the practical dermatopathology
series and it is stated in the introduction the monograph is
based on morphological descriptions of the individual entities
described.
After a standard introductory chapter on the biology of
human skin, the book is divided into six further chapters on
benign epidermal tumours, basal cell epithelioma, actinic kera-
tosis, Bowen's disease, keratoacanthoma and squamous cell
carcinomas. Thus the melanocytic lesions, the most important
problem for oncologists, are not included in this particular
volume. The book is very much aimed at a morphologist and
probably at a pathologist. There is little in each section of
aetiology or on experimental models of the individual lesions;
there are brief descriptions with a few illustrations of the
clinical appearances, and thereafter there are many pages of
high quality black and white photomicrographs of the mor-
phological, histological appearance of the lesions under discus-
sion. Treatment and management of the lesions is usually
consigned to a page at the end of each individual chapter. All
chapters are generously referenced.
I think many readers of the British Journal ofCancer would
find a book with rather more on current theories about aetio-
logy and current work on the role of for example, the ras
family of oncogenes and the P53 gene family in these lesions
discussed. Oncogenes are mentioned only very briefly and in
passing. Similarly I think many who are interested in the
morphological appearance of these lesions might prefer colour
photography. There is no doubt in the past few years the more
readily availability of colour illustrations in books of this type
has made them much more attractive, and in general much
more useful. At forty-five pounds the book is modestly priced,
but before purchasing, those interested should perhaps consult
a larger dermatopathology text such as the excellent one by
Phillip McKee, which is profusedly illustrated in colour and
consider whether or not the slightly greater expense of the
McKee volume could be justified.
R.M. MacKie
Palliative Care for People with Cancer
Edited by J. Penson and R. Fisher, London: Edward Arnold,
1991, 293 pp. £14.95.
This is an excellent book. The contributors are in touch with
the real world and they convey their wide experience in a
clear, factual style which all practitioners in this field will find
helpful. Although Palliative Care is a vast subject, this book
covers its practical, philosophical and spiritual aspects in an
admirably comprehensive fashion. It thus deserves a place as
an essential reference wherever cancer patients are cared for.
R.J. Osborne